Latest Health News
USDA Confirms HPAI Expansion in U.S. Commercial Poultry
USDA reports new highly pathogenic avian influenza (HPAI) cases in commercial flocks across Arkansas, Maryland, and Kansas, affecting nearly 900,000 birds nationwide in the past month. This underscores ongoing biosecurity risks in the poultry sector as winter surveillance intensifies.
No human cases linked yet, but vigilance remains high.
White House Previews Leaner U.S. Diet Rules for 2026
The White House and FDA are setting the stage for major 2026 food policy reset with simplified U.S. dietary guidelines. This aims to streamline regulations amid broader health and trade policy changes.
Impacts could include shifts in nutrition labeling and public health recommendations.
U.S. and Côte d'Ivoire Sign $937M Global Health MOU
The U.S. signed a five-year, $937 million health cooperation agreement with Côte d'Ivoire to enhance infectious disease surveillance and response. It promotes country ownership, co-investment, and self-reliance under the America First Global Health Strategy.
Focus areas include outbreak prevention and supply chain modernization.
ACA Subsidy Cliff Looms as Enhanced Premiums Expire
Enhanced Affordable Care Act subsidies expire today, potentially raising 2026 premiums and causing coverage losses. House Democrats plan a January extension push, but Senate prospects are dim post-shutdown.
Millions could face higher costs without legislative action.
UCF Nanoparticles Advance Radiation Therapy Safety
University of Central Florida researchers developed nanoparticles to prevent or repair radiation-induced inflammation and bone loss in cancer patients. Preliminary tests show safety and efficacy, potentially revolutionizing treatments.
Additional innovations include Silfoam for rapid wound closure.
Multiple Sclerosis Breakthrough Links Disease to Epstein-Barr Virus
U.S. researchers demonstrated a key connection between multiple sclerosis and the Epstein-Barr virus, affecting over 2.8 million globally. This raises hopes for a vaccine to eliminate a major disease trigger.
The January 2025 finding continues to inspire 2026 research momentum.
Generic Lenacapavir Set for HIV Prevention in 100 Countries by 2027
Affordable generic injectables of lenacapavir, a long-acting HIV prevention treatment, will reach about 100 nations by 2027. This offers a convenient alternative to daily pills, especially in low-income areas.
It promises to boost access and adherence globally.
DEA Extends Telehealth Flexibilities for Opioid Treatment Through 2026
DEA and HHS extended telehealth prescribing rules for opioid use disorder treatments, avoiding a lapse on January 1, 2026. The rule runs through December 31, 2026, maintaining access for patients.
This supports continued remote care amid regulatory evolution.
Axsome Therapeutics on Track for AXS-12 Narcolepsy NDA in January 2026
Axsome plans to submit FDA New Drug Application for AXS-12 to treat narcolepsy cataplexy by end of January 2026. The drug, backed by three efficacy trials and Orphan Drug status, modulates norepinephrine and dopamine.
CEO optimistic about new options for patients.
FV Hospital Expands Vietnam National Health Insurance from January 1, 2026
FV Hospital in Vietnam will apply National Health Insurance to all inpatient, outpatient, and emergency services starting January 1, 2026. This enhances accessibility and affordability for patients.
It marks a significant step in national healthcare integration.
Pathology Advances in Genomics and AI Gear Up for 2026 Challenges
Pathology sees momentum in long-read sequencing for neurological diseases and AI-digital workflow adoption. Workforce shortages persist, but innovations like Huntington’s progress monitoring advance precision diagnostics.
2026 emphasizes training, equity, and technology integration.
Clinical Labs Evolve with Omics, NGS, and Transplant Diagnostics for 2026
Laboratories advance multi-omics, next-generation sequencing, and cryo-EM for deeper biological insights and precision medicine. New transplant tools enable personalized immunosuppression to improve outcomes.
Sustainability and collaboration drive routine clinical adoption.